US Patent 7713973 Kinase inhibitors
Patent 7713973 was granted and assigned to Takeda Pharmaceutical Company on May, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 14 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+160 characters)
Article
Patent abstract
Compounds, pharmaceutical compositions and kits are provided for use with kinases that comprise a compound selected from the group consisting of:
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Bheema R. Paraselli0
David J. Hosfield0
Jeffrey A. Stafford0
Michael B. Wallace0
Nicholas Scorah0
Qing Dong0
Zhiyuan Zhang0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07713973 Kinase inhibitors US Patent 7713973 Kinase inhibitors
Infobox
Patent Number
077139730
Patent Number
77139730
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077139730
Date of Patent
May 11, 2010
0Patent Application Number
112516160
Date Filed
October 14, 2005
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07713973 Kinase inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07713973
Date of patent
May 11, 2010
Patent application number
11251616
Date Filed
October 14, 2005
Patent primary examiner
Find more entities like US Patent 7713973 Kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
